Three children in Connecticut have died over the past two months after overdosing on diphenhydramine, the active ingredient in Benadryl and dozens of other over-the-counter allergy and cold medications available on any drugstore shelf in America. The state's Office of the Child Advocate disclosed the deaths and issued a statewide advisory, but has released almost no details about who these children were, how old they were, or exactly how they got their hands on the drug.
That wall of silence from state officials should trouble every parent in the country. Diphenhydramine is in medicine cabinets from coast to coast. It requires no prescription. And it can kill a child who takes too much of it.
The Daily Mail reported that the Office of the Child Advocate urged parents to treat every medication, prescription or otherwise, as potentially dangerous and to store it where children cannot reach it. A spokesman for the agency put it plainly: "We want parents to be aware that any medication, including prescription and non-prescription medication, is potentially dangerous to children of all ages."
Dr. Krishnan Narasimhan, head of family medicine at Stamford Hospital, called the cluster of three deaths in just two months "unusual." As he told Connecticut Public Radio, according to the New York Post:
"That's unusual. And definitely a cause for concern because it's a lot."
State officials have not released the children's ages, their names, the cities where they lived, or the specific diphenhydramine product involved. They have offered no details about the circumstances surrounding any of the three deaths. That leaves parents guessing about whether these were accidental ingestions by toddlers, intentional misuse by older children, or something else entirely.
The lack of transparency matters. Parents cannot protect their kids from a risk they cannot see clearly. And the state's refusal to share even basic demographic or situational details makes it harder for families and pediatricians to calibrate the danger.
One question hanging over the Connecticut deaths is whether they are connected to the so-called "Benadryl challenge," a social media trend that first surfaced on TikTok in 2020. The dare encouraged young people, mostly teenagers and pre-teens, to take dangerously high doses of diphenhydramine to induce hallucinations. The results were predictable and grim.
The Office of the Child Advocate said it "cannot confirm such a connection" between the Connecticut deaths and the challenge. But the trend's history is hard to ignore.
In Texas, Dr. Stephanie Felton, associate medical director for the Cook Children's Medical Center emergency department, said in April that the hospital had recorded one recent death tied to the challenge. She told the Fort Worth Star-Telegram that while the hospital was not seeing as many overdoses as it did when the trend first exploded in 2020, the rise, primarily among teens and pre-teenagers, remained concerning. Cook Children's emergency department had treated more than 100 patients for diphenhydramine overdoses in the previous six months alone.
One hundred patients in six months at a single hospital. Three dead children in one state in two months. These are not abstract numbers. They are kids.
Diphenhydramine hydrochloride is sold under a variety of brand and generic names. Most Americans know it as Benadryl. It treats allergies, colds, itching. It is cheap, effective in proper doses, and everywhere.
But too much of it can cause a cascade of dangerous effects: elevated heart rate, seizures, agitation, hallucinations, urinary retention leading to kidney dysfunction, and arrhythmia. The FDA has warned that high doses can lead to heart problems, seizures, coma, or death.
That warning from the FDA came after the agency said it had become aware of teenagers ending up in emergency rooms or dying after participating in the TikTok-driven challenge. The agency's notice stated:
"We are aware of news reports of teenagers ending up in emergency rooms or dying after participating in the 'Benadryl Challenge' encouraged in videos posted on the social media application TikTok."
The FDA said it contacted TikTok directly and "strongly urged them to remove the videos from their platform and to be vigilant to remove additional videos that may be posted." The agency also advised parents to store diphenhydramine out of sight and reach of children and to lock up medications at risk of misuse by kids and teenagers.
TikTok has removed videos related to the challenge from its platform. A spokesman previously told the Daily Mail that the site's community guidelines do not allow content showing or promoting dangerous activities or challenges. When users search for the trend now, TikTok displays a message: "Be informed and aware. Some substances can be dangerous when used or misused."
That is a tepid warning for a platform that helped popularize a dare that has put children in emergency rooms and coffins.
There is currently no evidence that the trend still exists on social media sites. But the damage was done years ago, and the information, how much to take, what it supposedly feels like, does not disappear from the internet just because a platform scrubs a few videos. Kids talk. They text. They share. The challenge may be off TikTok, but the idea lives on.
When the trend first emerged, Johnson & Johnson, then Benadryl's parent company, called it "extremely concerning and dangerous" and warned consumers to stop participating immediately, adding that abuse or misuse of its products can lead to dangerous side effects with long-lasting consequences.
Benadryl is now owned by Kenvue, which provided a statement calling the social media trend "extremely dangerous" and saying it "should be stopped immediately." Kenvue added:
"We've taken action to stop this behavior from spreading and work with social media platforms and their safety teams to remove these dangerous posts, including any new content we identify in our monitoring. We also work with non-profit partners and healthcare professionals to educate on appropriate use and safe storage of [over-the-counter] products, including diphenhydramine-containing products."
Kenvue also urged consumers to follow label instructions and contact a healthcare professional with questions.
Connecticut's advisory told healthcare providers to warn families to identify and safely store medications containing diphenhydramine. That is sensible advice. But it is also the bare minimum.
Parents still do not know whether these three children found the drug in an unlocked cabinet, received it from a friend, or sought it out after seeing something online. They do not know whether the children were five years old or fifteen. They do not know whether any adult supervision failed, or whether the circumstances point to a systemic gap in how over-the-counter medications are regulated, packaged, or sold.
The Office of the Child Advocate has declined to provide those details. Without them, the public is left with a warning label and a body count.
The FDA said it was investigating and conducting a review to determine whether additional cases had been reported. It promised to update the public once the review was complete. Whether that update arrives with the urgency the situation demands remains to be seen.
This story follows a pattern Americans have seen before. A social media platform amplifies dangerous behavior. Children get hurt or die. The platform removes the content after the damage is done. The manufacturer issues a statement expressing concern. A government agency announces a review. And parents are left to wonder what they missed.
The adults in the room, the regulators, the platforms, the companies, all say the right things after the fact. The FDA urged TikTok to act. TikTok says it removed the content. Kenvue says it monitors for new posts. Everyone has a statement. Everyone expresses concern.
But three children in Connecticut are dead. More than a hundred showed up at a single Texas emergency department in six months. And the drug that did it is sitting in an unlocked cabinet in millions of American homes right now.
Safe storage is not a policy innovation. It is common sense, the kind that used to be assumed, not announced in a press advisory after children have already died. When a society needs a government agency to remind parents to lock up the allergy medicine, something deeper has broken down.
